Israel Englander’s CONMED CNMD Stock Holding History

Israel Englander’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100,000	Closed	-$3.54M	–	5924
2026 Q1	$3.54M	Buy	+100,000	New	+$4.07M	﹤0.01%	3310
2024 Q4	–	Sell	-10,000	Closed	-$719K	–	6020
2024 Q3	$719K	Buy	10,000 +5,000	+100%	+$353K	﹤0.01%	4539
2024 Q2	$347K	Buy	+5,000	New	+$365K	﹤0.01%	4825
2024 Q1	–	Sell	-50,000	Closed	-$5.48M	–	6235
2023 Q4	$5.48M	Sell	50,000 -20,000	-29%	-$2.07M	﹤0.01%	2711
2023 Q3	$7.06M	Buy	+70,000	New	+$8.04M	﹤0.01%	2382
2023 Q2	–	Sell	-2,000	Closed	-$208K	–	6172
2023 Q1	$208K	Sell	2,000 -3,000	-60%	-$290K	﹤0.01%	5147
2022 Q4	$443K	Buy	+5,000	New	+$415K	﹤0.01%	4830
2022 Q2	–	Sell	-10,000	Closed	-$1.49M	–	7031
2022 Q1	$1.49M	Sell	10,000 -32,000	-76%	-$4.47M	﹤0.01%	4135
2021 Q4	$5.95M	Buy	42,000 +32,000	+320%	+$4.53M	﹤0.01%	2717
2021 Q3	$1.31M	Buy	+10,000	New	+$1.31M	﹤0.01%	4389
2020 Q4	–	Sell	-30,000	Closed	-$2.36K	–	5235
2020 Q3	$2.36K	Sell	30,000 -20,000	-40%	-$1.63M	﹤0.01%	2474
2020 Q2	$3.6M	Buy	+50,000	New	+$3.48M	﹤0.01%	2067
2020 Q1	–	Sell	-20,000	Closed	-$2.24M	–	3925
2019 Q4	$2.24M	Buy	20,000 +15,000	+300%	+$1.6M	﹤0.01%	2552
2019 Q3	$480K	Buy	+5,000	New	+$469K	﹤0.01%	3291
2019 Q2	–	Sell	-10,000	Closed	-$832K	–	4089
2019 Q1	$832K	Buy	+10,000	New	+$727K	﹤0.01%	2975

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Israel Englander's CNMD Position: Q2 2026 in Review

Israel Englander increased its CONMED (CNMD) stake by 51% in Q2 2026, buying an estimated $1.39M and bringing the position to 114,609 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3274.

Israel Englander first reported a position in CNMD in Q2 2013 and has held it in 46 quarters since. The position peaked at $48.4M in Q4 2020. 245 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Israel Englander held 114,609 shares of CONMED worth $3.75M as of Q2 2026.
Israel Englander bought 38,700 CONMED shares in Q2 2026, an estimated $1.39M.
CONMED made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3274 holding.
Israel Englander first reported a position in CONMED in Q2 2013 and has held it in 46 quarters since.
Israel Englander's CONMED position peaked at $48.4M in Q4 2020.
245 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.